Skye Biologics, Inc. is a Southern California-based company focused on identifying, developing, and collaborating in the advancement of osteobiologics and natural regenerative biologics. Founded in 2006, the company aims to improve patient outcomes by facilitating the natural repair process of the body's tissues and musculoskeletal system. Skye Biologics offers a comprehensive line of human allograft tissues, including their unique BioECM Amniotic Biologics, Bone Fillers and Scaffolds, as well as Soft Tissue Grafts. The company operates within the Health Care, Medical Devices, and Wellness Beauty industries. Despite the absence of information regarding their headquarters, investment details, and investors, Skye Biologics demonstrates promise in the regenerative biologics sector with its innovative product offerings and commitment to enhancing patient outcomes.
There is no investment information
No recent news or press coverage available for Skye Biologics, Inc..